Bristol-Meyers, Pfizer Hid Eliquis Risks, $10M Suit Alleges

By Dani Kass (August 15, 2016, 4:57 PM EDT) -- Bristol-Myers Squibb and Pfizer Inc. have failed to disclose that their blockbuster blood thinner Eliquis has been linked to life-threatening conditions, including excessive bleeding, in a disregard for patient safety, according to a $10 million suit filed Friday in New York state court. 

Rhonda Hancock and her husband James say she was permanently injured from the ill-reported side effects of Eliquis, or apixaban. The drug companies have continued to make and promote the drug, which brought it nearly $2 million in 2015, despite knowing it can be fatal, the suit alleges.

"These representations were made by defendants with the intent of...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!